NBC Nightly News (4/17, story 7, 2:30, Williams) reported in its broadcast about the potential impact on the people from the allergy season as grass starts to grow and flowers start to bloom. NBC News interviewed Dr. Rachel Szekely from Cleveland Clinic and several people suffering from allergy about their experiences, before noting that FDA had “just approved” two “new prescription” tablets to “treat certain grass pollen allergies,” with both the tablets melting under the tongue. The report noted that “Grastek is for ages five years to 65 years old,” while Oralair is “for ages 10 to 65.” Meanwhile “another, Ragwitek, is approved for ragweed pollen.”
The AP (4/18) reported the FDA has “again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.” The AP noted that Ragwitek tablets “dissolve quickly under the tongue,” and patients need to take one every day, from three months before ragweed season begins until it ends, for a few years. Grastek received the agency’s approval Monday.
Had a pt with multiple congenital abnormalities: corpus callosum agenesis, septo optic dysplasia, blindness, with general convulsions, scoliosis, and cerebral palsy. He was being treated for pneumonia related seizures. Sweet and responsive kid with a super mom. She closely included me in his care, and left to up to me when his IV fell out through his thumb, needed his brace on, and needed to go back to bed after a 3-minute seizure on the lift.
Had a nurse ride me until half the shift. The pt was a neonate being treated for jaundice—easy. But the RN was just looking for something to play with and apparently it was my patience.
Got off early and made the 30 min drive home to binge (missed a lunch) and fall asleep in my unfolded clothes.